The Journal of Allergy and Clinical Immunology
Volume 113, Issue 6 , Pages 1178-1184, June 2004

Isocyanate vapor-induced antigenicity of human albumin

  • Adam V. Wisnewski, PhD

      Affiliations

    • From the Department of Internal Medicine, Yale School of Medicine, New Haven
  • ,
  • Meredith H. Stowe, PhD

      Affiliations

    • From the Department of Internal Medicine, Yale School of Medicine, New Haven
  • ,
  • André Cartier, MD

      Affiliations

    • Hôpital du Sacré-Coeur de Montréal
  • ,
  • Qing Liu, PhD

      Affiliations

    • From the Department of Internal Medicine, Yale School of Medicine, New Haven
  • ,
  • Jian Liu, MS

      Affiliations

    • From the Department of Internal Medicine, Yale School of Medicine, New Haven
  • ,
  • Liang Chen, PhD

      Affiliations

    • From the Department of Internal Medicine, Yale School of Medicine, New Haven
  • ,
  • Carrie A. Redlich, MD, MPH

      Affiliations

    • From the Department of Internal Medicine, Yale School of Medicine, New Haven
    • Corresponding Author InformationReprint requests: Adam V. Wisnewski, PhD, Yale School of Medicine, 333 Cedar Street, LCI-105, New Haven CT 06520.

Received 3 December 2003; received in revised form 22 January 2004; accepted 11 March 2004.

New Haven, Conn, and Montreal, Quebec, Canada

Background

The bioreactivity of isocyanate, a leading cause of occupational asthma, has led to uncertainty regarding the chemical's antigenicity and mechanisms that elicit immunopathology.

Objective

To understand better the biologically relevant antigenic forms of hexamethylene diisocyanate (HDI), commonly used in the auto body industry.

Methods

Human albumin was exposed to HDI vapors through a novel approach designed to model the air–liquid interface of the human airway. Vapor HDI-exposed albumin was characterized by electrophoresis, chemical substitution analysis, mass spectrometry, and serology studies on auto body shop workers (N = 203) and HDI asthmatics (N = 11).

Results

HDI vapors caused significant changes in the shape and/or charge of human albumin, which differed from albumin exposed to liquid phase HDI, with lower isocyanate substitution ratios and distinct electrophoretic mobility. Specific sites of vapor HDI conjugation to albumin were identified at His247 and Lys414. Vapor HDI-exposed albumin was specifically recognized by the humoral arm of the human immune system, with a strong dependence on albumin as the carrier. Vapor HDI-exposed albumin-specific IgG titers were significantly associated with HDI exposure (P = .001), and specific IgE was detectable in 55% (6/11) of isocyanate asthmatics versus 1.5% (3/203) of exposed healthy workers. Parallel studies using HDI-exposed albumin conjugates produced by previously published methods showed less significant associations of HDI-specific IgG and IgE with exposure and disease, respectively.

Conclusion

HDI-albumin conjugates produced by novel vapor phase exposure methods may be more physiologically relevant than those produced by previously published methods and of greater utility in characterizing the immune responses associated with HDI exposure and asthma.

Key words: Hexamethylene di-isocyanate, HDI, vapor, albumin, IgG, IgE, exposure, occupational asthma

Abbreviations used: HDI, Hexamethylene diisocyanate, MALDI, Matrix-assisted laser desorptive ionizing, MS, Mass spectrometry

 

 Supported by grants from the National Institutes of Health (HL62622, M01RR00125), National Institute of Occupational Safety and Health (OH3457) and National Institute of Environmental Health Sciences (ES00355).

PII: S0091-6749(04)01137-6

doi:10.1016/j.jaci.2004.03.009

The Journal of Allergy and Clinical Immunology
Volume 113, Issue 6 , Pages 1178-1184, June 2004